David Harder

Health Canada receives applications concerning clinical trials on a regular basis.  This time, the licensed producer of natural EU-GMP psilocybin and MDMA Optimi Health Corp. (OTCQX: OPTHF) together with ATMA Journey Centers say they intend to submit a Phase I clinical trial...